<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02845804</url>
  </required_header>
  <id_info>
    <org_study_id>HOST-ALPINE</org_study_id>
    <nct_id>NCT02845804</nct_id>
  </id_info>
  <brief_title>Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronary Atherosclerosis</brief_title>
  <acronym>HOST-ALPINE</acronym>
  <official_title>Harmonizing Optimal Strategy for Treatment of Coronary Atherosclerotic Lesions- Registry-based Study on the Effect and Safety of Xience Xpedition™/Alpine™, Everolimus-eluting Stent for Coronary Atherosclerotic Lesions: HOST-Alpine Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Abbott</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this study are

        1. To establish a prospective registry of the whole patients who received percutaneous
           coronary intervention with Xience Xpedition™/Alpine™ stent

        2. To evaulate the long-term efficacy and safety of coronary stenting with the Xience
           Xpedition™/Alpine™ stent

        3. To compare the long-term efficacy and safety of coronary stenting between the Xience
           Xpedition™/Alpine ™ stent and other contemporary drug-eluting stents which had
           established their own registry
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Secondary endpoints of this study are

      Stent thrombosis-24 hours(acute), 30 days(subacute), 1 year(late), every 1 year till 3
      years(very-late) after index PCI

      Target vessl failure

      Composite rate of cardiac death and any MI, 3 years

      Composite rate of all death and any MI

      Composite rate of all death, any MI, and any repeat revascularization

      Compliance and therapy interruptions with prescribed adjunctive antiplatelet therapy
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Target lesion failure</measure>
    <time_frame>12 months</time_frame>
    <description>Composite of cardiac death, non-fatal target vessel-related myocardial infarction (MI), and ischemia-driven target lesion revascularization (TLR)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Target vessel failure</measure>
    <time_frame>12 months</time_frame>
    <description>Composite of cardiac death, non-fatal target vessel related myocardial infarction, and ischemia-driven target vessel revascularization (TVR)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite rate of cardiac death and myocardial infarction</measure>
    <time_frame>12 months, 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite rate of all-cause death and any myocardial infarction</measure>
    <time_frame>12 months, 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite rate of all-cause death and any myocardial infarction, and any repeat revascularization</measure>
    <time_frame>12 months, 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of compliance and interruptions with prescribed adjunctive antiplatelet therapy</measure>
    <time_frame>12 months, 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical device and procedural success rate</measure>
    <time_frame>intraoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis</measure>
    <time_frame>within 24 hours, 1 - 30 days, 31 days - 1 year, after 1 year</time_frame>
    <description>acute (within 24 hours), subacute (1 - 30 days), late (31 days - 1 year), very late (&gt;1 year)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1533</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Percutaneous Coronary Intervention</condition>
  <condition>Acute Coronary Syndrome</condition>
  <condition>Angina Pectoris</condition>
  <arm_group>
    <arm_group_label>Alpine</arm_group_label>
    <description>The patients who received percutaneous coronary intervention with Xience Xpedition™/Alpine™</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Alpine</intervention_name>
    <arm_group_label>Alpine</arm_group_label>
    <other_name>Everolimus-eluting stent</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All coronary arterial disease patients who received percutaneous coronary intervention with
        Xience Xpedition™/Alpine™ stent(s)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient agrees to participate in this study by signing the informed consent form.

        Alternatively, a legally authorized patient representative may agree to the patient's
        participation in this study and sign the informed consent form

        Exclusion Criteria:

          -  There are no exclusion criteria for this registry.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hyo-soo Kim, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hyo-soo Kim, MD, PhD</last_name>
    <phone>+82-2-2072-2226</phone>
    <email>hyosoo@snu.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kangwon National University Hospital</name>
      <address>
        <city>Chuncheon</city>
        <state>Gangwon-do</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yong-Hoon Kim</last_name>
    </contact>
    <investigator>
      <last_name>Yong-Hoon Kim</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wonju Severance Christian Hospital</name>
      <address>
        <city>Wonju</city>
        <state>Gangwon-do</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jung-Han Yoon</last_name>
    </contact>
    <investigator>
      <last_name>Jung-Han Yoon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sejong General Hospital</name>
      <address>
        <city>Bucheon</city>
        <state>Gyeonggi-do</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young-Jin Choi</last_name>
    </contact>
    <investigator>
      <last_name>Young-Jin Choi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hallym University Sacred Heart Hospital</name>
      <address>
        <city>Anyang</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang-Ho Jo, MD,PhD</last_name>
    </contact>
    <investigator>
      <last_name>Sang-Ho Jo, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Busan Paik Hospital</name>
      <address>
        <city>Busan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tae-Hyun Yang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kosin University Gospel Hospital</name>
      <address>
        <city>Busan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeong Ho Heo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dankook University Hospital</name>
      <address>
        <city>Cheonan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Byung-Eun Park, MD,PhD</last_name>
    </contact>
    <investigator>
      <last_name>Byung-Eun Park, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SoonChunHyang University Cheonan Hospital</name>
      <address>
        <city>Cheonan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang-Ho Park</last_name>
    </contact>
    <investigator>
      <last_name>Sang-Ho Park</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chungbuk National University Hospital</name>
      <address>
        <city>Chongju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jang-Hwan Bae, MD,PhD</last_name>
      <email>drcorazon@hanmail.net</email>
    </contact>
    <investigator>
      <last_name>Jang-Hwan Bae, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yongnam University Medical Center</name>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jong-Sun Park, MD,PhD</last_name>
      <email>pjs@medical.yu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Jong-Sun Park, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chonnam National University Hospital</name>
      <address>
        <city>Gwangju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Myung-Ho Jeong</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wonkwang University Hospital</name>
      <address>
        <city>Iksan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seok-Kyo Oh, MD,PhD</last_name>
      <email>oskcar@wonkwang.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Seok-Kyo Oh, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inha University Hospital</name>
      <address>
        <city>Inchon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seong-Il Woo, MD,PhD</last_name>
      <email>wjswgs@naver.com</email>
    </contact>
    <investigator>
      <last_name>Seong-Il Woo, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Presbyterian Medical Center</name>
      <address>
        <city>Jeonju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Je-Young Rhew, MD,PhD</last_name>
      <email>jkrhew@hanafos.com</email>
    </contact>
    <investigator>
      <last_name>Je-Young Rhew, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>In-Ho Chae, MD,PhD</last_name>
    </contact>
    <investigator>
      <last_name>In-Ho Chae, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gangbuk Samsung Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ki-Cheol Sung, MD,PhD</last_name>
    </contact>
    <investigator>
      <last_name>Ki-Cheol Sung, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hanyang University Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young-Hyo Lim</last_name>
    </contact>
    <investigator>
      <last_name>Young-Hyo Lim</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kangdong Sacred Heart Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyoo-Rok Han, MD,PhD</last_name>
      <email>krheart@hallym.or.kr</email>
    </contact>
    <investigator>
      <last_name>Kyoo-Rok Han, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seoul Boramae Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang-Hyun Kim, MD,PhD</last_name>
      <email>shkimmd@snu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Sang-Hyun Kim, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyo-soo Kim, MD, PhD</last_name>
      <phone>+82-2-2072-2223</phone>
      <email>hyosoo@snu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Hyo-soo Kim, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bon-Kwon Koo, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hyun-Jae Kang, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jung-Kyu Han, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sang-Eun Lee, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 24, 2016</study_first_submitted>
  <study_first_submitted_qc>July 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2016</study_first_posted>
  <last_update_submitted>July 26, 2016</last_update_submitted>
  <last_update_submitted_qc>July 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Hyo-Soo Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>coronary artery disease</keyword>
  <keyword>percutaneous coronary intervention</keyword>
  <keyword>everolimus-eluting stents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Angina Pectoris</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Everolimus</mesh_term>
    <mesh_term>Sirolimus</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

